Mylan's Latest Focalin ANDA Brings Novartis IP Suit
Celgene Corp. and Novartis Pharma AG has slapped Mylan Pharmaceuticals Inc. with a lawsuit in New Jersey federal court alleging the generic and specialty pharmaceutical company violated six of their patents when...To view the full article, register now.
Already a subscriber? Click here to view full article